Breakthrough Physics Discovery Could Reshape Our Understanding of Alzheimer’s
A new study from Auburn University provides new insights into neuronal connections, offering hope for the treatment of ...
Neurons use simple physics to maintain their connections, but these processes change in Alzheimer's patients
Scientists at Auburn University have uncovered a fundamental principle of how brain cells stay connected, and their discovery ...
STAT3d
In a first, Eli Lilly to connect patients to telehealth providers of Alzheimer’s care
In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.
Nature1y
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
These emerging concepts are exemplified by Alzheimer's disease, in which amyloid β-protein oligomers adversely affect synaptic structure and plasticity. Findings in other neurodegenerative ...
News Medical1mon
Study reveals how air pollution contributes to Alzheimer's disease
Scientists at Scripps Research have discovered how a chemical change ... Alzheimer's mouse models, the re-engineered CRTC1 restored the activation of genes required for memory formation and ...
News-Medical.Net on MSN13d
Probiotic drink kefir shows promise in preventing Alzheimer’s
Kefir, a probiotic-rich fermented milk, shows potential in reducing neuroinflammation, oxidative stress, and beta-amyloid ...
Acumen Pharmaceuticals Completes Enrollment of ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...